Leukocyte adhesion deficiency

Last updated: November 01, 2022

Leukocyte adhesion deficiency

step 1 hemato

step 1 hemato

Blood histology
Blood components
Erythropoietin
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Iron deficiency anemia
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Lead poisoning
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Sickle cell disease (NORD)
Hereditary spherocytosis
Aplastic anemia
Megaloblastic anemia
Vitamin B12 deficiency
Acute intermittent porphyria
Porphyria cutanea tarda
Hemophilia
Vitamin K deficiency
Hemolytic-uremic syndrome
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Heparin-induced thrombocytopenia
Antithrombin III deficiency
Antiphospholipid syndrome
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Polycythemia vera (NORD)
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Langerhans cell histiocytosis
Multiple myeloma
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Hematopoietic medications
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Transplant rejection
Graft-versus-host disease
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Isolated primary immunoglobulin M deficiency
Thymic aplasia
DiGeorge syndrome
Severe combined immunodeficiency
Adenosine deaminase deficiency
Ataxia-telangiectasia
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chediak-Higashi syndrome
Chronic granulomatous disease
Complement deficiency
Asplenia
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Glucocorticoids
Folate (Vitamin B9) deficiency
Cell cycle
Contact dermatitis
Atopic dermatitis
Bullous pemphigoid
Pemphigus vulgaris
Erythema multiforme
Stevens-Johnson syndrome
HIV and AIDS: Pathology review
Tuberculosis: Pathology review

Flashcards

Leukocyte adhesion deficiency

0 of 9 complete

Transcript

Watch video only

Leukocyte adhesion deficiency is a rare inherited immunodeficiency which develops because a group of immune cells called phagocytes fail to bind to the blood vessel wall, and therefore cannot get to the site of inflammation or tissue injury.

Normally, phagocytes, which are mostly neutrophils, circulate in the blood waiting for a signal that something’s wrong somewhere in the body.

As soon as this signal comes, in the form of cytokines which are pro-inflammatory molecules, they try to speed over to the affected tissue.

But to get there, they first have to pass through the endothelial cells that line the blood vessel wall.

Getting through the endothelial cells is known as extravasation and involves multiple steps.

First, the endothelium expresses molecules called selectins, which binds to sialyl-Lewis X, a carbohydrate that’s found on the surface of phagocytes, making them slow down and roll along the vessel wall.

Second, is a step called adhesion.

That’s basically a tight interaction between cellular adhesion molecules on the surface of endothelial cells, and integrins on the surface of the phagocytes.

Third, phagocytes manage to transmigrate or squeeze around the endothelial junctions, which are the sites of connection between two adjacent endothelial cells.

Fourth, the phagocytes use the concentration gradient of the cytokine signals to move towards the area of inflammation.

This process is critical for destroying invading pathogens, in particular bacteria and fungi.

In fact, after a long battle with bacterial or fungal cells, phagocytes, especially neutrophils, die and can form a collection of pus, which can accumulate in a closed tissue space, developing into an abscess.

The process of extravasation is also essential for wound healing, where phagocytes help remove dead and damaged cells.

In addition to typical settings of wound healing, this function of phagocytes is required soon after birth.

That’s because once the umbilical cord is cut, the cells within the cord being to die, and these dead cells are engulfed by phagocytes.

That process helps the dry umbilical cord separate from the baby’s abdomen.

In leukocyte adhesion deficiency, there’s a mutation in a gene that encodes some of the molecules that mediate the interaction between phagocytes and endothelial cells.

There are two major types, based on the step that’s affected.

Leukocyte adhesion deficiency type I is by far the most common and results from a failure to express CD18, which is a subunit of integrin molecules.

Sources

  1. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Bates' Guide to Physical Examination and History Taking" LWW (2016)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "A Novel Leukocyte Adhesion Deficiency III Variant: Kindlin-3 Deficiency Results in Integrin- and Nonintegrin-Related Defects in Different Steps of Leukocyte Adhesion" The Journal of Immunology (2011)
  7. "Clinical Manifestations and Laboratory Findings in Patients with Leukocyte Adhesion Deficiency (LAD)" Immunology and Genetics Journal (2022)